VANSEN PHARMA INC. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
VANSEN PHARMA INC. reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of -$2.48 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-12-04.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2013-12-04
- VANSEN PHARMA INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2013-09-30 was -$2.48M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 101 month |
|---|---|---|---|
| 2013-09-30 | -$2.48M 10-Q · filed 2013-12-04 | -$2.48M 10-Q · filed 2013-12-04 | -$2.48M 10-Q · filed 2013-12-04 |